The trademark application was filed by ABT Holding Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on May 2, 2021, and it was registered by office on August 9, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on January 11, 2024.
Goods And Services
The mark was filed in class 5 with following description of goods:
Stem cells for medical or clinical medical use
Pharmaceutical compositions comprising stem cells for use in regenerative medicine
Pharmaceutical compositions comprising stem cells for the treatment of neurological, cardiovascular, inflammatory and immune diseases, critical care disorders, conditions and injuries, solid organ transplantation, wound healing and orthopedics.